Showing results (261-270 of 410) with videos related to

Sort By:
Pageof 41
European Journal of Cancer (Oxford, England : 1990)|May 19, 2016
RECIST 1.1-Update and clarification: From the RECIST committeeLawrence H Schwartz, Saskia Litière, Elisabeth de Vries, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot TrialChrisann Kyi, Vladimir Roudko, Rachel Sabado, et al.
Science (New York, N.Y.)|March 31, 2018
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunityLucas Ferrari de Andrade, Rong En Tay, Deng Pan, et al.
The Lancet. Oncology|March 9, 2017
iRECIST: guidelines for response criteria for use in trials testing immunotherapeuticsLesley Seymour, Jan Bogaerts, Andrea Perrone, et al.
Journal of Pain and Symptom Management|January 2, 2025
Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical TrialsSarah N Price, Ju-Whei Lee, Ilana F Gareen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma VaccinesJohn M Goldberg, David E Fisher, George D Demetri, et al.
Cancer Cell|April 10, 2023
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanomaKatie M Campbell, Meelad Amouzgar, Shannon M Pfeiffer, et al.
Clinical and Translational Science|June 20, 2024
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b studyJoaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United StatesLawrence Flaherty, Omid Hamid, Gerald Linette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2024
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial DataGeorgina V Long, Evan J Lipson, F Stephen Hodi, et al.
Pageof 41